ARRIVENT BIOPHARMA INC (AVBP) Institutional Shareholders

ARRIVENT BIOPHARMA INC (AVBP) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $971.91M in AVBP holdings during the latest filing period.

Suvretta Capital Management, Llc is currently the largest disclosed institutional shareholder of AVBP tracked by InsiderSet, reporting ownership valued at approximately $101.53M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $131.24M, representing an estimated gain of +29.26% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 67% of the total disclosed AVBP value among the investors covered in this analysis. Major shareholders include Suvretta Capital Management, Llc, Infinitum Asset Management, Llc, Hhlr Advisors, Ltd., and several other long-term asset managers with concentrated positions in ARRIVENT BIOPHARMA INC (AVBP).

This page ranks the largest institutional AVBP shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

139

Total Reported Value

$971.91M

Largest Holder

Suvretta Capital Management, Llc

Largest Position

$101.53M

Insider Transactions (90d)

0

Latest Filing Quarter

Q2 2026

New Institutional Positions

160

Funds Exiting Positions

0

Page 1 of 3
NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Suvretta Capital Management, Llc2.75%4,401,083$101,532,985$131,240,295+$29,707,310+29.26%
Infinitum Asset Management, Llc11.98%4,148,923$95,715,654$123,720,884+$28,005,230+29.26%
Hhlr Advisors, Ltd.5.42%3,929,117$90,644,729$117,166,269+$26,521,540+29.26%
Orbimed Advisors Llc1.52%3,027,328$69,840,457$90,274,921+$20,434,464+29.26%
Fmr Llc0.00%3,016,132$69,582,163$89,941,056+$20,358,893+29.26%
Blackrock, Inc.0.00%2,530,301$58,374,044$75,453,576+$17,079,532+29.26%
Octagon Capital Advisors Lp5.03%1,971,054$45,472,216$58,776,830+$13,304,614+29.26%
Novo Holdings A/S3.63%1,942,142$44,805,216$57,914,674+$13,109,458+29.26%
Sofinnova Investments, Inc.1.96%1,696,752$39,144,069$50,597,145+$11,453,076+29.26%
Vanguard Capital Management Llc0.00%1,528,893$35,271,562$45,591,589+$10,320,027+29.26%
General Catalyst Group Management, Llc18.79%1,494,786$34,484,713$44,574,519+$10,089,806+29.26%
State Street Corp0.00%1,421,415$32,792,044$42,386,595+$9,594,551+29.26%
Vivo Capital, Llc1.71%885,916$20,438,082$26,418,015+$5,979,933+29.26%
Goldman Sachs Group Inc0.00%853,427$19,688,560$25,449,193+$5,760,633+29.26%
Geode Capital Management, Llc0.00%803,652$18,544,348$23,964,903+$5,420,555+29.23%
Point72 Asset Management, L.P.0.03%748,195$17,260,859$22,311,175+$5,050,316+29.26%
Hsg Holding Ltd0.86%663,308$13,982,533$19,779,845+$5,797,312+41.46%
Fund 1 Investments, Llc1.50%499,990$11,534,769$14,909,702+$3,374,933+29.26%
Ubs Group Ag0.00%486,263$11,218,087$14,500,363+$3,282,276+29.26%
Balyasny Asset Management L.P.0.02%426,281$9,834,303$12,711,699+$2,877,396+29.26%
Millennium Management Llc0.01%425,923$9,826,044$12,701,024+$2,874,980+29.26%
D. E. Shaw & Co., Inc.0.01%368,795$8,508,101$10,997,467+$2,489,366+29.26%
Logos Global Management Lp0.42%350,000$8,074,500$10,437,000+$2,362,500+29.26%
Northern Trust Corp0.00%268,812$6,201,493$8,015,974+$1,814,481+29.26%
Charles Schwab Investment Management Inc0.00%258,772$5,969,870$7,716,581+$1,746,711+29.26%
Vanguard Portfolio Management Llc0.00%253,852$5,856,366$7,569,867+$1,713,501+29.26%
Nomura Holdings Inc0.05%242,050$5,584,094$7,217,931+$1,633,837+29.26%
Vanguard Fiduciary Trust Co0.00%217,127$5,009,120$6,474,727+$1,465,607+29.26%
Ameriprise Financial Inc0.00%180,028$4,153,246$5,368,435+$1,215,189+29.26%
Affinity Asset Advisors, Llc0.24%175,000$4,037,250$5,218,500+$1,181,250+29.26%
Citadel Advisors Llc0.00%166,157$3,833,242$4,954,802+$1,121,560+29.26%
Woodline Partners Lp0.01%147,639$3,406,032$4,402,595+$996,563+29.26%
Adar1 Capital Management, Llc0.20%141,814$3,271,649$4,228,893+$957,244+29.26%
Morgan Stanley0.00%128,546$2,965,556$3,833,242+$867,686+29.26%
Dimensional Fund Advisors Lp0.00%126,525$2,917,975$3,772,976+$855,001+29.30%
Polymer Capital Management (Hk) Ltd0.40%122,276$2,820,907$3,646,270+$825,363+29.26%
Burkehill Global Management, Lp0.11%100,000$2,307,000$2,982,000+$675,000+29.26%
E Fund Management Co., Ltd.0.06%93,953$2,167,496$2,801,678+$634,182+29.26%
Tema Etfs Llc0.06%57,034$1,981,361$1,700,754-$280,607-14.16%
Bank Of America Corp0.00%80,208$1,850,398$2,391,803+$541,405+29.26%
Wellington Management Group Llp0.00%78,213$1,804,374$2,332,312+$527,938+29.26%
Bank Of New York Mellon Corp0.00%75,448$1,740,585$2,249,859+$509,274+29.26%
Alps Advisors Inc0.01%47,074$1,635,351$1,403,747-$231,604-14.16%
Qube Research & Technologies Ltd0.00%70,317$1,622,213$2,096,853+$474,640+29.26%
Moody Aldrich Partners Llc0.27%44,044$1,530,089$1,313,392-$216,697-14.16%
Barclays Plc0.00%65,408$1,508,962$1,950,467+$441,505+29.26%
Xtx Topco Ltd0.03%63,002$1,453,456$1,878,720+$425,264+29.26%
Citigroup Inc0.00%41,265$1,433,546$1,230,522-$203,024-14.16%
Nuveen, Llc0.00%56,839$1,311,276$1,694,939+$383,663+29.26%
Squarepoint Ops Llc0.00%55,432$1,278,816$1,652,982+$374,166+29.26%

Frequently asked questions about AVBP

  • Who owns the most AVBP stock?

    The largest holders of AVBP are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for ARRIVENT BIOPHARMA INC (AVBP).

  • Is AVBP widely held by superinvestors?

    Many widely followed stocks like AVBP appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly AVBP is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.